PCPaul Cauchi

Paul Cauchi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul Cauchi has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Secondary extraocular extension of choroidal melanoma following primary photodynamic therapy

    by Nadeem Atwan, Timothy Beckman, Hardeep S. Mudhar, Fiona Roberts, Julie Connolly, Paul Cauchi, Vikas Chadha, Umiya Harley, Paul Rundle, Hibba Quhill

    Secondary extraocular extension (SEOE) following conservative treatment of choroidal melanoma (CM) is extremely rare, and its occurrence in patients treated with primary photodynamic therapy (PDT) has not been documented in the literature so far. We present three cases from our combined experience in the United Kingdom (UK). Retrospective, observational case series. All cases of patients treated with PDT, based on the TAP protocol with some deviations, for CM who experienced SEOE were included, from two of the four national ocular oncology centres in the UK. Clinical, radiological, histopathological, and surgical procedural data are presented. In total, at two of the four national ocular oncology centres in the UK, only three patients previously treated with PDT for CM were observed to develop SEOE during their follow up. All patients were treated with PDT after extensive counselling of all treatment options. All displayed local tumour control following initial treatment. SEOE occurred at a mean of 42.3 months [range 24-66] after treatment. SEOE was identified following enucleation for suspected intraocular clinical recurrence, or on surveillance ocular imaging (US and MRI). During ongoing follow up, two patients developed liver metastases, one remains metastasis-free to date. Given our combined experience, the estimated incidence of SEOE of choroidal melanoma following PDT was 1.3-1.6% across two ocular oncology services in the United Kingdom. Local radiotherapy remains the mainstay of treatment for small CM due to its superior local tumour control rates. Prior to this study, there had been no reports of SEOE following PDT for CM, so surveillance for recurrence was not designed to detect this complication. This series establishes that SEOE is a rare but important potential risk following PDT, and patients should be both counselled of this, and monitored for it. We suggest that long term follow-up of these patients should include interval ocular ultrasound to monitor for local recurrence and SEOE. Going forward, it may be appropriate to limit the use of primary PDT to those who would otherwise decline treatment of their melanoma.

  • Open Access

    Is an image-based eyelid management service safe and effective?

    by Matthew Gillam, Osman Younus, Shi-Pei Loo, Julie Connolly, Paul Cauchi, Marilena Gregory, Suzy Drummond, Vikas Chadha

    Introduction: The COVID-19 pandemic created a requirement for reduced patient contact and reduced capacity in clinics. We previously published results of an Image-Based Eyelid Lesion Management Service (IBELMS) which was found non-inferior to traditional face-to-face clinic at diagnosing lesions and identifying eyelid malignancies. We now present first-year safety and efficacy data from this service. Methods: Data were collected retrospectively on all patients seen in NHS Greater Glasgow and Clyde eyelid photography clinics from 30th September 2020 to 29th September 2021, including referral source and diagnosis, time to clinic review, treatment and patient outcomes. Results: 808 patients were included in the study. Chalazion was the most common diagnoses recorded (38.4%). There was a statistically significant decrease in mean time from referral to appointment time between the first 4 months and last 4 months of the service (93 days to 22 days, p ≤ 0.0001). 266 (33%) of patients were discharged following photographs, 45 (6%) were discharged for non-attendance and 371 (46%) were booked for a minor procedure. 13 biopsy-confirmed malignant lesions were identified; only 3 had been referred as suspected malignancy. 23 patients out of 330 with at least 6 months follow up (7%) were re-referred within 6 months of treatment or discharge; however, none of them with a missed periocular malignancy. Discussion: Eyelid photography clinics effectively reduce patient waiting times and maximise clinic capacity. They accurately identify eyelid lesions including malignancies with a low re-referral rate. We propose that an image-based service for eyelid lesions is a safe and effective way of managing such patients.


  • Post-enucleation outcomes of patients with uveal melanoma in Scotland

    by Deep Sarode, Tara McClay, Fiona Roberts, Julie Connolly, Paul Cauchi, Vikas Chadha

    Background/Objectives To investigate post-enucleation outcomes and assess the effect of extrascleral extension (ESE) on these outcomes for patients with uveal melanoma (UM) managed at a tertiary referral centre in Scotland. Subjects/Methods Retrospective review of all cases of UM managed by the Scottish Ocular Oncology Service for which enucleation was undertaken between 13/03/2008 and 31/12/2020. Primary outcomes were length of survival, time-to-metastasis (TTM) and local recurrence rate. Secondary outcomes were the effects of the presence of ESE, ESE size, and the use of adjuvant external beam radiotherapy (EBRT) on the primary outcomes. Results Of 172 enucleated UMs, 32 (18.6%) had ESE. Over a median follow-up period of 33.7 months (range = 1.1–163.7 months), 91 (52.9%) patients died. The median length of all-cause survival of 54.1 months (range = 1.1–163.7 months). One-year, 5-year, and 10-year survival rates were 84.8%, 49.1%, and 30.9%, respectively. Eighty-four (49.7%) patients had metastatic disease. The median TTM of 42.2 months (range = 0.4–106.8 months). Proportions of patients who developed metastases within 1-year, 5-years and 10-years post-enucleation were 22.7%, 52.8%, and 71.8%, respectively. There was one instance of local orbital recurrence. ESE was associated with a significantly shorter length of survival (p = 0.03). There was a trend towards a shorter length of survival and TTM with ESE > 5 mm and those who received adjuvant EBRT. Conclusions ESE was present in one-sixth of our cohort and was associated with a significantly shorter length of survival, particularly in the presence of ESE > 5 mm or high-risk characteristics warranting adjuvant EBRT. This data will aid prognostication of the patients in our service.


  • Consensus statement for metastatic surveillance of uveal melanoma in Scotland

    by Vikas Chadha, Paul Cauchi, Wilma Kincaid, Ashita Waterston, Stefano Schipani, Sachin Salvi, Oliver Cram, Diana Ritchie

    Ophthalmic treatments are successful in managing uveal melanomas achieving good local control. However, a large number still metastasise, primarily to the liver, resulting in mortality. There is no consensus across the world on the mode, frequency, duration or utility of regular liver surveillance for metastasis and there are no published protocols. The Scottish Ocular Oncology Service (SOOS) constituted a Scottish Consensus Statement Group (SCSG) which included ocular oncologists, medical oncologists, radiologists and a uveal melanoma patient as a lay member. This group carried out an extensive review of literature followed by discussions to arrive at a consensus regarding surveillance planning for posterior uveal melanoma patients in Scotland. The Consensus Statement would provide a framework to guide each patient’s surveillance plan and provide all patients with clarity and transparency on the issue. The SCSG was unable to find adequate evidence on which to base the strategy. The consensus statement recommends a risk-stratified approach to surveillance for these patients dividing them into low to medium-risk and high-risk groups defining the mode and duration of surveillance for each. It supplements the UK-wide Uveal Melanoma National Guidelines and allows a more uniform consensus-based approach to surveillance in Scotland. It has been adopted nationally by all health care providers in Scotland as a guideline and is available to patients on a publicly accessible website.


  • Real world outcomes of a virtual ocular oncology service in Scotland

    by Osman Younus, Matthew Gillam, Paul Cauchi, Vikas Chadha, Julie Connolly


  • An image-based eyelid lesion management service—evaluation of a pilot

    by J. Hind, M. Edington, K. McFall, E. Salina, C. Diaper, S. Drummond, D. Tejwani, M. E. Gregory, J. Connolly, P. Cauchi, et al.

    Background/aims Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require face-to-face (F2F) review, in accordance with current post-COVID-19 principles of social distancing. Methods Patients with lid lesions attending an oculoplastics clinic were assessed by consultant oculoplastic surgeons in an F2F consultation (Arm A). The lesions were photographed by a professional clinical photographer (Arm B) and by an optometrist with a handheld digital camera (Arm C). These images were reviewed by independent consultants masked to the outcome of the F2F clinical encounter. Data were collected prospectively including patient demographics, diagnosis, suspicion of malignancy and management. The image-based clinic results were compared to the F2F clinic results. Results Ninety-five patients were included. Clinical diagnoses were compared for intra-observer variability and substantial agreement was demonstrated between gold-standard F2F clinic visit (Arm A) and Arm B (Ƙ = 0.708) and C (Ƙ = 0.776). There was no statistically significant difference in the rate of discharge and all cases of malignancy were either identified or flagged for F2F review in the image-based arms. Conclusion This pilot demonstrated substantial diagnostic agreement of image-based diagnoses with F2F consultation and image review alone did not miss any cases of malignancy.


  • Outcomes of cataract surgery in patients previously treated with orbital radiotherapy

    by Jennifer BMSc MBChB FRCOphth Hind, Aaron BSc (Hon) MBChB FRCOphth Jamison, Stefano Schipani, Julie MSc MBChB PhD FRCOphth Connolly, Paul Mbbs Frcophth Cauchi, Vikas Mbbs Chadha

    Purpose: To quantify the risks for cataract surgery in patients who have previously undergone external beam radiotherapy (EBRT). Setting: Tertiary ophthalmology and oncology hospital. Design: Retrospective case series. Methods: Patients treated with orbital EBRT at the Beatson West of Scotland Cancer Centre between 2001 and 2019 were identified, and clinical records were reviewed to identify those who had subsequently undergone cataract surgery. Preoperative and postoperative case records, and operation records, were reviewed to identify demographic data and data regarding complications and surgical outcomes. Results: 46 eyes (of 33 patients) were included. The indications for EBRT included thyroid eye disease, lymphoma, choroidal metastases, and other orbital malignancies. Mean corrected preoperative Snellen visual acuity was 20/100 (range 20/30 to 20/2000) improving to 20/25 (20/12 to 20/160, 1-way analysis of variance P < .01). Mean visual gain was 0.5 logMAR (−0.9 to 1.9). There was 1 case of posterior capsule (PC) rupture with vitreous loss (2%). Dense PC plaque was noted intraoperatively in 19.5% (n = 9). 13% (n = 6) required Nd:YAG laser posterior capsulotomy. There were 6 cases (13%) of cystoid macular edema (CME). Conclusions: Visual outcomes after cataract surgery in this cohort of patients were similar to those obtained in a nationwide cohort. EBRT seemed to be associated with an increased incidence of intraoperative PC plaque, postoperative CME (which in most cases settled with treatment), and need for posterior capsulotomy.


  • Open Access

    Very late local recurrence of uveal melanoma following successful trans-scleral local resection

    by Aaron Jamison, Fiona Roberts, Wilma Kincaid, Julie Connolly, Paul Cauchi, Vikas Chadha

  • Telemedicine in Oculoplastics: The Real-Life Application of Video Consultation Clinics

    by Aaron Jamison, Charles Diaper, Suzannah Drummond, Deepak Tejwani, Maria Elena Gregory, Paul Cauchi, Kevin Crofts, Vikas Chadha

    Purpose: Our oculoplastic service piloted a new video consultation (VC) clinic in response to the COVID-19 pandemic. Data were collected to determine whether specific patients are better suited to VC, and to quantify the true benefit of VC in patients that successfully attended. Methods: Data were collected prospectively on predetermined data collection forms, including consultation duration, diagnosis, management plan, and issues that arose. Results: 37.8% of new referrals and 60.9% of return patients were vetted as suitable for VC. Of those invited to attend, 83.4% agreed to a VC appointment. Of the patients appointed to a VC clinic, 71.7% (new)/75% (return) successfully completed VC, 14.9%/15.8% attempted a VC which ultimately failed, and 13.4%/9.2% did not attend. VC successfully prevented face-to-face consultation in 81.3% of new cases and 91.1% of returns. Ectropion, entropion and dermatochalasis (new referrals), and postoperative follow-up (return patients) were well suited to VC, while patients with “watery eye” (new), and lid or conjunctival lesions (return), often required face-to-face consultation. Problems (most common issues with patients connecting to the consultation, video quality, and audio quality) were encountered during 50.3% of calls, although 82.6% of attempted calls were ultimately successful. Age was not associated with the proportion of calls that were successful. Conclusions: VC is a useful tool for oculoplastic patients, irrespective of age, as long as the patient’s notes/referrals are carefully vetted to determine suitability. Patients with ectropion, entropion and dermatochalasis, and postoperative reviews are better suited to VC than those with “watery eye,” lid lesions, and conjunctival lesions.